The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Efficacy and Adverse Effects of Ginkgo Biloba for Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis
Open accessAbstract
BACKGROUND: Research into Ginkgo biloba has been ongoing for many years, while the benefit and adverse effects of Ginkgo biloba extract EGb761 for cognitive impairment and dementia has been discussed controversially. OBJECTIVE: To discuss new evidence on the clinical and adverse effects of standardized Ginkgo biloba extract EGb761 for cognitive impairment and dementia. METHODS: MEDLINE, EMBASE, Cochrane, and other relevant databases were searched in March 2014 for eligible randomized controlled trials of Ginkgo biloba EGb761 therapy in patients with cognitive impairment and dementia. RESULTS: Nine trials met our inclusion criteria. Trials were of 22-26 weeks duration and included 2,561 patients in total. In the meta-analysis, the weighted mean differences in change scores for cognition were in favor of EGb761 compared to placebo (-2.86, 95%CI -3.18; -2.54); the standardized mean differences in change scores for activities in daily living (ADLs) were also in favor of EGb761 compared to placebo (-0.36, 95%CI -0.44; -0.28); Peto OR showed a statistically significant difference from placebo for Clinicians' Global Impression of Change (CGIC) scale (1.88, 95%CI 1.54; 2.29). All these benefits are mainly associated with EGb761 at a dose of 240 mg/day. For subgroup analysis in patients with neuropsychiatric symptoms, 240 mg/day EGb761 improved cognitive function, ADLs, CGIC, and also neuropsychiatric symptoms with statistical superiority than for the whole group. For the Alzheimer's disease subgroup, the main outcomes were almost the same as the whole group of patients with no statistical superiority. Finally, safety data revealed no important safety concerns with EGb761. CONCLUSIONS: EGb761 at 240 mg/day is able to stabilize or slow decline in cognition, function, behavior, and global change at 22-26 weeks in cognitive impairment and dementia, especially for patients with neuropsychiatric symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients
Cummings, J. L. (1997) · Neurology · doi:10.1212/wnl.48.5_suppl_6.10s · Cited by 2,017
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (2011) · Neurology · doi:10.1212/01.wnl.0000400650.92875.cf · Cited by 1,495
Lyketsos, C. G., Steinberg, M., Tschanz, J. T., Norton, M. C., Steffens, D. C., & Breitner, J. C. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.708 · Cited by 1,144
Point and 5‐year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study
Steinberg, M., Shao, H., Zandi, P., Lyketsos, C. G., Welsh‐Bohmer, K. A., Norton, M. C., Breitner, J. C. S., Steffens, D. C., & Tschanz, J. T. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1858 · Cited by 780
Brain Infarction and the Clinical Expression of Alzheimer Disease-Reply
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550020046024 · Cited by 674
DeKosky, S. T. (2008) · JAMA · doi:10.1001/jama.2008.683 · Cited by 670
Schneider, L. S., Olin, J. T., Doody, R. S., Clark, C. M., Morris, J. C., Reisberg, B., Schmitt, F. A., Grundman, M., Thomas, R. G., & Ferris, S. H. (1997) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199700112-00004 · Cited by 647
Ginkgo biloba for cognitive impairment and dementia
Birks, J., & Grimley Evans, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003120.pub3 · Cited by 581
Tan, C.-C., Yu, J.-T., Wang, H.-F., Tan, M.-S., Meng, X.-F., Wang, C., Jiang, T., Zhu, X.-C., & Tan, L. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132690 · Cited by 484
Self-citationThe prevalence of dementia in urban and rural areas of China
Jia, J., Wang, F., Wei, C., Zhou, A., Jia, X., Li, F., Tang, M., Chu, L., Zhou, Y., Zhou, C., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.01.012 · Cited by 441
Ginkgo Biloba Extract (EGb 761) and CNS Functions Basic Studies and Clinical Applications
DeFeudis, F., & Drieu, K. (2000) · Current Drug Targets · doi:10.2174/1389450003349380 · Cited by 441
Geda, Y. E., Roberts, R. O., Knopman, D. S., Petersen, R. C., Christianson, T. J. H., Pankratz, V. S., Smith, G. E., Boeve, B. F., Ivnik, R. J., Tangalos, E. G., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.10.1193 · Cited by 438
Wu, Y., Wu, Z., Butko, P., Christen, Y., Lambert, M. P., Klein, W. L., Link, C. D., & Luo, Y. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3448-06.2006 · Cited by 406
Vellas, B., Coley, N., Ousset, P.-J., Berrut, G., Dartigues, J.-F., Dubois, B., Grandjean, H., Pasquier, F., Piette, F., Robert, P., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70206-5 · Cited by 398
Apolipoprotein E in Alzheimer's Disease: An Update
Yu, J.-T., Tan, L., & Hardy, J. (2014) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071013-014300 · Cited by 394
Self-citationBastianetto, S., Ramassamy, C., Doré, S., Christen, Y., Poirier, J., & Quirion, R. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00069.x · Cited by 379
Kanowski, S., Herrmann, W., Stephan, K., Wierich, W., & Hörr, R. (1996) · Pharmacopsychiatry · doi:10.1055/s-2007-979544 · Cited by 369
Snitz, B. E. (2009) · JAMA · doi:10.1001/jama.2009.1913 · Cited by 336
NLRP1 Inflammasome Activation Induces Pyroptosis of Hematopoietic Progenitor Cells
Masters, S. L., Gerlic, M., Metcalf, D., Preston, S., Pellegrini, M., O’Donnell, J. A., McArthur, K., Baldwin, T. M., Chevrier, S., Nowell, C. J., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.027 · Cited by 313
Effects of Ginkgo biloba in dementia: systematic review and meta-analysis
Weinmann, S., Roll, S., Schwarzbach, C., Vauth, C., & Willich, S. N. (2010) · BMC Geriatrics · doi:10.1186/1471-2318-10-14 · Cited by 297
NLRP1-Dependent Pyroptosis Leads to Acute Lung Injury and Morbidity in Mice
Kovarova, M., Hesker, P. R., Jania, L., Nguyen, M., Snouwaert, J. N., Xiang, Z., Lommatzsch, S. E., Huang, M. T., Ting, J. P.-Y., & Koller, B. H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201065 · Cited by 271
Wang, H.-F., Yu, J.-T., Tang, S.-W., Jiang, T., Tan, C.-C., Meng, X.-F., Wang, C., Tan, M.-S., & Tan, L. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-307659 · Cited by 269
Self-citationMazza, M., Capuano, A., Bria, P., & Mazza, S. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01409.x · Cited by 237
Mixed Dementia—the Most Common Cause of Dementia
KORCZYN, A. D. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04807.x · Cited by 219
Schneider, L., DeKosky, S., Farlow, M., Tariot, P., Hoerr, R., & Kieser, M. (2005) · Current Alzheimer Research · doi:10.2174/156720505774932287 · Cited by 182
Herrschaft, H., Nacu, A., Likhachev, S., Sholomov, I., Hoerr, R., & Schlaefke, S. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.03.003 · Cited by 180
Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761)
Abdel-Kader, R., Hauptmann, S., Keil, U., Scherping, I., Leuner, K., Eckert, A., & Müller, W. E. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.011 · Cited by 167
DONGEN, M. C. J. M. V. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00003-9 · Cited by 164
Le Bars, P. L., Kieser, M., & Itil, K. Z. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017242 · Cited by 164
A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline
Dodge, H. H., Zitzelberger, T., Oken, B., Howieson, D. B., & Kaye, J. A. (2008) · Neurology · doi:10.1212/01.wnl.0000303814.13509.db · Cited by 162
Wang, J., Yu, J., Wang, H.-F., Meng, X., Wang, C., Tan, C., & Tan, L. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308112 · Cited by 159
Self-citationThe Alzheimer's Disease Activities of Daily Living International Scale (ADL-ISY)
Reisberg, ., Finkel, S. I., Overall, J. E., Schmidt-Gollas, N., Kanowski, S., Lehfeld, H., HULLA, F. W., Sclan, S. G., Wilms, H.-U., Heininger, K., et al. (2001) · International Psychogeriatrics · doi:10.1017/s1041610201007566 · Cited by 155
Ihl, R., Bachinskaya, N. Y., Korczyn, A. D., Vakhapova, V., Tribanek, M., Hoerr, R., & Napryeyenko, O. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2662 · Cited by 148
Yoshitake, T., Yoshitake, S., & Kehr, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00580.x · Cited by 138
Effects of EGb 761® Ginkgo biloba Extract on Mitochondrial Function and Oxidative Stress
Eckert, A., Keil, U., Kressmann, S., Schindowski, K., Leutner, S., Leutz, S., & Müller, W. E. G. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-40449 · Cited by 137
CNS Targets for multi-functional drugs in the treatment of Alzheimer?s and Parkinson?s diseases
Youdim, M. B. H., & Buccafusco, J. J. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-004-0214-z · Cited by 135
Si, G., Preuss, U. W., Wong, J. W. M., Hoerr, R., Kaschel, R., Bachinskaya, N. Y., & the GIMCIPlus Study Group (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4103 · Cited by 132
Kanowski, S., & Hoerr, R. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-45117 · Cited by 129
Ihl, R., Tribanek, M., Bachinskaya, N. Y., & for the GOTADAY Study Group (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1291217 · Cited by 128
Ginkgo biloba Special Extract in Dementia with Neuropsychiatric Features
Napryeyenko, O., & Borzenko, I. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1296579 · Cited by 123
Ginkgo Biloba Extract (EGb 761) in Alzheimers Disease: Is there Any Evidence?
Ramassamy, C., Longpré, F., & Christen, Y. (2007) · Current Alzheimer Research · doi:10.2174/156720507781077304 · Cited by 107
Kanowski, S., Herrmann, W. M., Stephan, K., Wierich, W., & Hörr, R. (1997) · Phytomedicine · doi:10.1016/s0944-7113(97)80021-9 · Cited by 99
Edwards, E. R., Spira, A. P., Barnes, D. E., & Yaffe, K. S. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2187 · Cited by 92
Napryeyenko, O., Sonnik, G., & Tartakovsky, I. S. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.353 · Cited by 85
Factor structure and scoring of the SKT test battery
Kim, Y. S., Nibbelink, D. W., & Overall, J. E. (1993) · Journal of Clinical Psychology · doi:10.1002/1097-4679(199301)49:1<61::aid-jclp2270490109>3.0.co;2-b · Cited by 85
Age-related effects of Ginkgo biloba extract on synaptic plasticity and excitability
Williams, B., Watanabe, C. M. H., Schultz, P. G., Rimbach, G. H., & Krucker, T. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.10.008 · Cited by 83
The Gottfries-Bråne-Steen Scale: Validity, Reliability and Application in Anti-Dementia Drug Trials
Bråne, G., Gottfries, C. G., & Winblad, B. G. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051230 · Cited by 83
Lyketsos, C. G., Steinberg, M., Breitner, J. C. S., Tschanz, J. T., Norton, M. C., & Steffens, D. C. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)83436-3 · Cited by 81
Development and Validation of the Geriatric Evaluation by Relative's Rating Instrument (Gerri)
Schwartz, G. E. (1983) · Psychological Reports · doi:10.2466/pr0.1983.53.2.479 · Cited by 81
Brondino, N., SILVESTRI, A. D., Re, S., Lanati, N., Thiemann, P., Verna, A., Emanuele, E., & Politi, P. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/915691 · Cited by 79
Kehr, J., Yoshitake, S., Ijiri, S., Koch, E., Nöldner, M., & Yoshitake, T. (2012) · International Psychogeriatrics · doi:10.1017/s1041610212000567 · Cited by 65
Ihl, R., Grass‐Kapanke, B., Jänner, M., & Weyer, G. (1999) · Pharmacopsychiatry · doi:10.1055/s-2007-991102 · Cited by 35
MIXED BRAIN PATHOLOGIES ACCOUNT FOR MOST DEMENTIA CASES IN COMMUNITY-DWELLING OLDER PERSONS
Nandigam, R. N. K. (2008) · Neurology · doi:10.1212/01.wnl.0000307675.38908.39 · Cited by 33
Költringer, P., Langsteger, W., & Eber, O. (1995) · Clinical hemorheology · Cited by 30
Ginkgo biloba for cognitive impairment and dementia
McGraw, C. (2010) · Primary Health Care · doi:10.7748/phc.20.9.14.s24 · Cited by 30
Ginkgo biloba for Preventing Cognitive Decline in Older Adults: A Randomized Trial
Dungan, J. S. (2010) · Yearbook of Obstetrics Gynecology and Women s Health · doi:10.1016/s1090-798x(10)79304-8 · Cited by 24
Cited by
Dominguez, L. J., Veronese, N., Vernuccio, L., Catanese, G., Inzerillo, F., Salemi, G., & Barbagallo, M. (2021) · Nutrients · doi:10.3390/nu13114080 · Cited by 433
Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety
Shaito, A., Thuan, D. T. B., Phu, H. T., Nguyen, T. H. D., Hasan, H., Halabi, S., Abdelhady, S., Nasrallah, G. K., Eid, A. H., & Pintus, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00422 · Cited by 437
Pohl, F., & Kong Thoo Lin, P. (2018) · Molecules · doi:10.3390/molecules23123283 · Cited by 272
Dou, K.-X., Tan, M.-S., Tan, C.-C., Cao, X.-P., Hou, X.-H., Guo, Q.-H., Tan, L., Mok, V., & Yu, J.-T. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0457-9 · Cited by 171
Self-citationLiu, X., Hao, W., Qin, Y., Decker, Y., Wang, X., Burkart, M., Schötz, K., Menger, M. D., Fassbender, K., & Liu, Y. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.01.011 · Cited by 149
Metadata
- Authors
- Tan, M.-S., Yu, J.-T., Tan, C.-C., Wang, H.-F., Meng, X.-F., Wang, C., Jiang, T., Zhu, X.-C., & Tan, L.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2014-11-21
- Volume
- 43
- Issue
- 2
- Pages
- 589-603
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1512883130
- Cited by
- 253
- References
- 62
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.